Valneva stock jumps as chikungunya vaccine wins Europe approval (NASDAQ:VALN)
2024-07-01
designer491/iStock via Getty Images Valneva (NASDAQ:VALN) shares jumped 8.4% premarket on Monday after the vaccine company secured marketing authorization in Europe for its chikungunya vaccine, Ixchiq. Ixchiq is the world’s only licensed chikungunya vaccine and has been approved for the prevention of disease caused by the chikungunya virus in individualsContinue Reading